Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$373M |
| 2 |
Costco
COST
|
+$283M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$270M |
| 4 |
Pfizer
PFE
|
+$240M |
| 5 |
Microsoft
MSFT
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$274M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$228M |
| 3 |
GAS
AGL Resources Inc
GAS
|
+$216M |
| 4 |
TE
TECO ENERGY INC
TE
|
+$136M |
| 5 |
Charter Communications
CHTR
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.75% |
| 2 | Healthcare | 13.12% |
| 3 | Financials | 12.46% |
| 4 | Consumer Staples | 9.7% |
| 5 | Industrials | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Emerson Radio
MSN
$7.99M
| $831K | ﹤0.01% |
814,800
+32,700
| +4% | +$26K |
|
|
FTD
2652
DELISTED
FTD Companies, Inc. Common Stock
FTD
| $829K | ﹤0.01% |
40,300
-28,622
| -42% | -$687K |
|
2653
ONE Gas
OGS
$5.05B
| $822K | ﹤0.01% |
13,300
+4,800
| +56% | +$304K |
|
|
PCO
2654
DELISTED
Pendrell Corporation - Class A
PCO
| $818K | ﹤0.01% |
1,193
+270
| +29% | +$178K |
|
|
XENT
2655
DELISTED
Intersect ENT, Inc
XENT
| $813K | ﹤0.01% |
+51,300
| New | +$773K |
|
|
LQ
2656
DELISTED
La Quinta Holdings Inc.
LQ
| $813K | ﹤0.01% |
+72,700
| New | +$844K |
|
|
HEOP
2657
DELISTED
Heritage Oaks Bancorp
HEOP
| $813K | ﹤0.01% |
99,100
+13,600
| +16% | +$111K |
|
|
CGNT
2658
DELISTED
Cogentix Medical, Inc.
CGNT
| $812K | ﹤0.01% |
446,137
+109,474
| +33% | +$142K |
|
|
LITB
2659
LightInTheBox
LITB
$56.7M
| $811K | ﹤0.01% |
47,400
+2,150
| +5% | +$41K |
|
|
VXX
2660
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
| $811K | ﹤0.01% |
5,950
+1,225
| +26% | +$196K |
|
2661
Gray Television
GTN
$520M
| $810K | ﹤0.01% |
+78,150
| New | +$851K |
|
2662
Noodles & Co
NDLS
$98M
| $810K | ﹤0.01% |
+21,275
| New | +$1.25M |
|
|
SPNC
2663
DELISTED
Spectranetics Corp
SPNC
| $808K | ﹤0.01% |
+32,222
| New | +$752K |
|
|
JONE
2664
DELISTED
Jones Energy, Inc.
JONE
| $802K | ﹤0.01% |
12,250
+10,140
| +481% | +$627K |
|
2665
Key Tronic
KTCC
$42.8M
| $798K | ﹤0.01% |
107,157
-25,743
| -19% | -$194K |
|
|
SHI
2666
DELISTED
Sinopec Shanghai Petrochemical Co., Ltd.
SHI
| $796K | ﹤0.01% |
15,550
+7,100
| +84% | +$357K |
|
2667
Landmark Bancorp
LARK
$197M
| $795K | ﹤0.01% |
48,878
+2,280
| +5% | +$36.3K |
|
|
UBFO
2668
DELISTED
United Security Bancshares
UBFO
| $789K | ﹤0.01% |
128,573
+7,108
| +6% | +$42.7K |
|
|
MAGN
2669
Magnera Corp
MAGN
$443M
| $787K | ﹤0.01% |
2,792
-85
| -3% | -$23.6K |
|
|
BCOM
2670
DELISTED
B Communications Ltd
BCOM
| $784K | ﹤0.01% |
33,400
+2,100
| +7% | +$50.9K |
|
|
SBR
2671
Sabine Royalty Trust
SBR
$1.06B
| $781K | ﹤0.01% |
21,257
+13,600
| +178% | +$500K |
|
2672
Chemung Financial Corp
CHMG
$403M
| $780K | ﹤0.01% |
26,900
+226
| +0.8% | +$6.72K |
|
2673
iRadimed
IRMD
$1.11B
| $780K | ﹤0.01% |
+45,900
| New | +$850K |
|
2674
Xenon Pharmaceuticals
XENE
$6.21B
| $779K | ﹤0.01% |
96,200
+47,700
| +98% | +$368K |
|
|
BRT
2675
BRT Apartments
BRT
$268M
| $776K | ﹤0.01% |
96,960
+10,400
| +12% | +$77.6K |
|
Similar funds
Jim Simons's Q3 2016 Portfolio in Review
As of Q3 2016, Jim Simons held 3,713 positions worth $56.6B, up 7.7% from $52.5B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $1.92B of net new capital in Q3 2016, opening 414 new positions and adding to 1,834 existing holdings. Its largest new stake was FedEx: 811,400 shares worth $142M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was CVS Health, an estimated $274M trimmed.
- Jim Simons's largest Q3 2016 buy was FedEx: 811,400 shares worth $142M.
- Jim Simons added most to Alphabet (Google) Class A in Q3 2016, an estimated $373M increase.
- Jim Simons's biggest Q3 2016 reduction was CVS Health, cutting an estimated $274M.
- Jim Simons fully exited EMC CORPORATION in Q3 2016, selling an estimated $228M.
- Jim Simons's ten largest holdings make up 7.9% of its $56.6B portfolio in Q3 2016.
- Jim Simons opened 414 new positions and closed 416 in Q3 2016.
- Jim Simons's portfolio value rose 7.7% quarter-over-quarter to $56.6B.
Based on Renaissance Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.